DTC's
Chronic-Risk
Screenings &
Assessments
Screen. Test. Treat.
TriageIQ™ | Chronic-Risk Pre-Screeners
DTC's
Chronic-Risk
Screenings &
Assessments
Screen. Test. Treat.
One Room. Earlier Insight. DTC helps ACO/VBC and PCP networks use existing clinic space to identify chronic-risk signals earlier, support care-gap discovery, and guide provider-directed follow-up.
Diabetes Testing Centers™ (DTC) began with diabetes-related testing and has evolved into a broader chronic-risk detection platform for modern primary care. Designed to integrate inside existing PCP clinics using as little as one dedicated room, DTC helps primary care practices identify chronic-risks and connect it to focused, non-invasive assessment pathways inside the clinical workflow they already use. Our model is simple:
Screen using TriageIQ™.
Test with DTC assessments.
Treat through provider-directed care.
TriageIQ™ serves as the intake-level pre-screener that helps capture what patients report but rarely volunteer before it is missed, minimized, or left undocumented. DTC assessments help providers evaluate those signals when clinically appropriate through focused testing pathways that may support medical necessity, care planning, monitoring, referrals, or follow-up decisions. The treating provider remains responsible for diagnosis, treatment, monitoring, referrals, and patient care. DTC does not replace the provider’s judgment. It helps organize the path from early risk recognition to appropriate clinical action.
Most chronic diseases do not begin with a diagnosis. They often begin years earlier with subtle changes in how a patient feels, functions, moves, thinks, sleeps, sees, or tolerates daily life. Patients may explain these changes away as aging, stress, fatigue, pain, or 'just getting older'. Many never mention them during a routine visit unless they are asked in a structured way. That is the gap DTC is designed to close.
By capturing these early indicators at intake, documenting them while the patient is already present, and connecting them to DTC assessments when appropriate, practices can create a clearer path from early risk recognition to timely testing, monitoring, referral, or provider-directed care.
DTC was founded by former family practice owners who saw firsthand how often chronic risks are missed until patients have already begun suffering preventable damage. That experience, combined with enterprise healthcare leadership in diagnostics and diabetes, shaped DTC’s development of scalable, non-invasive, billable programs for modern primary care.
DTC adds structured pre-screening, focused assessments, and triage routing without a separate clinic or disruption to daily operations. Today, with access to a national network of more than 20,000 independent practices, DTC helps providers bring earlier detection, focused testing, and appropriate care direction into the clinical workflow they already use.
No separate clinic.
No major workflow disruption.
No waiting for silent risks to surface as complications.
The visit does not change, only the clinical insight it produces does.
Find Signals Sooner
The earliest warning signs often appear where the patient is — in symptoms, functional changes, behavioral shifts, pain patterns, and daily-life concerns that may surface before they are fully documented in the medical record.
TriageIQ™ Adult is designed to support intake both in-clinic and at-home, giving providers a consistent way to capture patient-reported risk signals before the visit, during intake, or through remote outreach. It helps organize those signals so providers can better determine whether focused screeners, assessments, testing, care-gap review, or additional diagnostic pathways may be appropriate.
TriageIQ™ Adult serves as the broad front-end pre-screener for the largest immediately addressable clinical population, helping identify patient-reported chronic-risk signals across multiple areas of clinical concern that may warrant provider review, focused screening, testing, follow-up, care-gap review, or care-management consideration.
TriageIQ™ Geriatric adds an age-focused layer for older adults, where risk is often more complex and may involve function, cognition, mobility, medication burden, caregiver support, post-discharge vulnerability, social needs, behavioral health concerns, and care-management opportunities.
Together, TriageIQ™ Adult and TriageIQ™ Geriatric help move intake from a passive questionnaire to an actionable pre-screener — capturing patient-reported risk signals earlier, organizing them and help providers decide where attention may be needed next.
TriageIQ™ is a non-diagnostic, patient-administered, intake pre-screener that identifies structured risk signals across multiple areas of clinical concern before the visit begins.
Turn Intake to Insight
The clinical case for earlier testing is not theoretical—it is measurable, documentable, and supported by written patient-reported findings captured at intake. By converting what patients may already be experiencing into structured documentation before the provider encounter, practices may better support the clinical rationale and medical necessity for appropriate follow-up testing, assessment, monitoring, or care planning.
Chronic damage accumulates long before symptoms become obvious, leaving providers to intervene later when care is more reactive, costly, and complex. The challenge is that most primary care workflows are not built to consistently capture risk during that earlier window. Patients present with a chief complaint and providers regularly respond to what is reported.
DTC exists to help practices find what others miss and act on those signals through earlier, more accessible testing. By connecting structured pre-screening with focused in-clinic or remote testing, DTC helps providers identify risk earlier, support medical-necessity documentation, and guide patients toward appropriate next steps before silent risks become serious complications.
The providers who benefit most are not adding complexity. They’re unlocking clinical value already present in their existing patient panel and visit flow by using a structured pathway to surface risk earlier, document it clearly, and move patients toward timely care.
Find What Others Miss
Following National Guidelines
National guidelines are clear. What is less clear in most busy practices is how to meet them consistently within existing visit structures without adding staff, extending appointment times, or relying entirely on provider recall. Until now.
Most guidelines and quality measures focus on one condition at a time. Real-world care is different. Patients often present with overlapping risks, incomplete complaints, and silent conditions that may not be obvious during a short visit.
TriageIQ™ helps surface patient-reported risk signals at intake and organizes them for provider review. Those signals may support appropriate next steps when clinically indicated, including focused screening, assessment, testing, referral, follow-up, or care-management consideration.
DPN testing deserves specific attention because neuropathy may be one of the earliest measurable warning signs of broader chronic-risk progression. Early nerve changes may appear before symptoms are clearly reported, while loss of protective sensation may increase concern for falls, wounds, infection, and amputation risk.
DPN is not only a foot-health concern, it may be one of the earliest visible warning signs—helping providers determine whether additional focused pathways may be clinically appropriate.
Neuropathy May Signal More
DTC organizes the path from screen to test. Start with TriageIQ™ at intake to identify patient-reported risk signals early and organize them for provider review. From there, your clinic can determine where focused screening, assessment, testing, referral, follow-up, or care-management consideration may be appropriate.
Getting Started Is Simple
Start with TriageIQ™ at Intake
Identify potential risk signals early and consistently.
Review Patient-Reported Risk Signals
See where patients may warrant focused screening, testing, referral, follow-up, or care-management consideration.
Prioritize the Highest-Impact Pathways First
Some patients may need next-step review right away, while broader clinic patterns often become clearer within the first 30 to 90 days of consistent use.
Note: Ancillary-ready clinics are often better equipped to turn risk signals into testing, follow-up, and referrals.
Schedule a meeting to Build Your Rollout Plan. We’ll help determine the best starting point, review program options, and provide a financial pro forma based on your location, workflow, and payor mix so implementation begins with a clear path to deployment.
From Signals to Tests